83
Views
5
CrossRef citations to date
0
Altmetric
Letters

The demographic, genetic, and clinical characteristics of Brazilian subjects enrolled in the Transthyretin Amyloidosis Outcomes Survey

, , , , , & show all
Pages 103-104 | Received 15 Nov 2016, Accepted 01 Feb 2017, Published online: 22 Apr 2017
 

Declaration of interest

The THAOS registry and the analyses presented here are sponsored by Pfizer. Editorial support was provided by Diane Hoffman, PhD, and Mary Kunjappu, PhD, of Engage Scientific Solutions and was funded by Pfizer. MWC received support from Pfizer as a clinical trial investigator, to attend scientific meetings, and as a consultant. MWC is a THAOS scientific board member. ACB has received support from Pfizer to attend scientific meetings. RM and M-LO are full-time employees of Pfizer and hold stock and/or stock options. DF and RCP have no conflict of interest to report.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.